Tilray Brands, Inc. Selling Expense
Tilray Brands, Inc. (TLRY) reported Selling Expense of $49.33 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-28.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingExpense · last filed 2026-07-28
- Tilray Brands, Inc. selling expense for the quarter ending 2026-05-31 was $14.01M, a 1.93% decline year-over-year.
- Tilray Brands, Inc. selling expense for the quarter ending 2026-02-28 was $10.62M, a 23.65% decline year-over-year.
- Tilray Brands, Inc. selling expense for the quarter ending 2025-11-30 was $11.78M, a 27.11% decline year-over-year.
- Tilray Brands, Inc. selling expense for the quarter ending 2025-08-31 was $12.92M, a 10.55% increase year-over-year.
- Tilray Brands, Inc. selling expense for fiscal 2026 was $49.33M, a 11.98% decline from fiscal 2025.
- Tilray Brands, Inc. selling expense for fiscal 2025 was $56.04M, a 50.51% increase from fiscal 2024.
- Tilray Brands, Inc. selling expense for fiscal 2024 was $37.23M, a 6.87% increase from fiscal 2023.
- Tilray Brands, Inc. selling expense for fiscal 2023 was $34.84M, a 0.25% decline from fiscal 2022.
| Period end | Selling Expense 3 month | Selling Expense 6 month | Selling Expense 9 month | Selling Expense 12 month |
|---|---|---|---|---|
| 2026-05-31 | $14.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $24.62M derived: sum of 2 quarters · filed 2026-07-28 | $36.41M derived: sum of 3 quarters · filed 2026-07-28 | $49.33M 10-K · filed 2026-07-28 |
| 2026-02-28 | $10.62M 10-Q · filed 2026-04-01 | $22.40M derived: sum of 2 quarters · filed 2026-04-01 | $35.32M 10-Q · filed 2026-04-01 | $49.60M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-11-30 | $11.78M 10-Q · filed 2026-01-08 | $24.70M 10-Q · filed 2026-01-08 | $38.99M derived: sum of 3 quarters · filed 2026-07-28 | $52.89M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-08-31 | $12.92M 10-Q · filed 2025-10-09 | $27.20M derived: sum of 2 quarters · filed 2026-07-28 | $41.11M derived: sum of 3 quarters · filed 2026-07-28 | $57.27M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-05-31 | $14.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $28.19M derived: sum of 2 quarters · filed 2026-07-28 | $44.35M derived: sum of 3 quarters · filed 2026-07-28 | $56.04M 10-K · filed 2026-07-28 |
| 2025-02-28 | $13.90M 10-Q · filed 2026-04-01 | $30.07M derived: sum of 2 quarters · filed 2026-04-01 | $41.76M 10-Q · filed 2026-04-01 | $54.55M derived: sum of 4 quarters · filed 2026-07-28 |
| 2024-11-30 | $16.16M 10-Q · filed 2026-01-08 | $27.85M 10-Q · filed 2026-01-08 | $40.65M derived: sum of 3 quarters · filed 2026-07-28 | $50.64M derived: sum of 4 quarters · filed 2026-07-28 |
| 2024-08-31 | $11.69M 10-Q · filed 2025-10-09 | $24.49M derived: sum of 2 quarters · filed 2026-07-28 | $34.48M derived: sum of 3 quarters · filed 2026-07-28 | $42.06M derived: sum of 4 quarters · filed 2026-07-28 |
| 2024-05-31 | $12.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $22.79M derived: sum of 2 quarters · filed 2026-07-28 | $30.37M derived: sum of 3 quarters · filed 2026-07-28 | $37.23M 10-K · filed 2026-07-28 |
| 2024-02-29 | $9.99M 10-Q · filed 2025-04-08 | $17.58M derived: sum of 2 quarters · filed 2025-04-08 | $24.44M 10-Q · filed 2025-04-08 | $33.48M derived: sum of 4 quarters · filed 2025-07-29 |
| 2023-11-30 | $7.58M 10-Q · filed 2025-01-10 | $14.44M 10-Q · filed 2025-01-10 | $23.49M derived: sum of 3 quarters · filed 2025-07-29 | $29.94M derived: sum of 4 quarters · filed 2025-07-29 |
| 2023-08-31 | $6.86M 10-Q · filed 2024-10-10 | $15.91M derived: sum of 2 quarters · filed 2025-07-29 | $22.36M derived: sum of 3 quarters · filed 2025-07-29 | $32.03M derived: sum of 4 quarters · filed 2025-07-29 |
| 2023-05-31 | $9.05M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-29 | $15.50M derived: sum of 2 quarters · filed 2025-07-29 | $25.17M derived: sum of 3 quarters · filed 2025-07-29 | $34.84M 10-K · filed 2025-07-29 |
| 2023-02-28 | $6.45M 10-Q · filed 2024-04-09 | $16.12M derived: sum of 2 quarters · filed 2024-04-09 | $25.79M 10-Q · filed 2024-04-09 | $35.44M derived: sum of 4 quarters · filed 2024-10-10 |
| 2022-11-30 | $9.67M 10-Q · filed 2024-01-09 | $19.34M 10-Q · filed 2024-01-09 | $28.98M derived: sum of 3 quarters · filed 2024-10-10 | $37.62M derived: sum of 4 quarters · filed 2024-10-10 |
| 2022-08-31 | $9.67M 10-Q · filed 2024-10-10 | $19.31M derived: sum of 2 quarters · filed 2024-10-10 | $27.95M derived: sum of 3 quarters · filed 2024-10-10 | $37.16M derived: sum of 4 quarters · filed 2024-10-10 |
| 2022-05-31 | $9.64M derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | $18.28M derived: sum of 2 quarters · filed 2024-07-30 | $27.49M derived: sum of 3 quarters · filed 2024-07-30 | $34.93M 10-K · filed 2024-07-30 |
| 2022-02-28 | $8.64M 10-Q · filed 2023-04-10 | $17.85M derived: sum of 2 quarters · filed 2023-04-10 | $25.28M 10-Q · filed 2023-04-10 | $33.81M derived: sum of 4 quarters · filed 2023-07-26 |
| 2021-11-30 | $9.21M 10-Q · filed 2023-01-09 | $16.64M 10-Q · filed 2023-01-09 | $25.17M derived: sum of 3 quarters · filed 2023-07-26 | $31.32M derived: sum of 4 quarters · filed 2023-07-26 |
| 2021-08-31 | $7.43M 10-Q · filed 2022-10-07 | $15.96M derived: sum of 2 quarters · filed 2023-07-26 | $22.11M derived: sum of 3 quarters · filed 2023-07-26 | $28.19M derived: sum of 4 quarters · filed 2023-07-26 |
| 2021-05-31 | $8.53M derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-26 | $14.68M derived: sum of 2 quarters · filed 2023-07-26 | $20.76M derived: sum of 3 quarters · filed 2023-07-26 | $26.58M 10-K · filed 2023-07-26 |
| 2021-02-28 | $6.16M 10-Q · filed 2022-04-06 | $12.23M derived: sum of 2 quarters · filed 2022-04-06 | $18.05M 10-Q · filed 2022-04-06 | |
| 2020-11-30 | $6.08M 10-Q · filed 2022-01-10 | $11.90M 10-Q · filed 2022-01-10 | ||
| 2020-08-31 | $5.82M 10-Q · filed 2021-10-07 | |||
| 2020-05-31 | $18.98M 10-K · filed 2022-07-28 | |||
| 2019-05-31 | $3.75M 10-K · filed 2021-07-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |